卓昇有限公司–最專業科學研究供應商
The CAMA-1 line was established by J. Fogh at Sloan-Kettering in 1975 from cells in the pleural effusion of a patient with carcinoma of the breast. An ampule frozen in May of 1978 at passage 21 was provided to us in June of 1991.
ABC-TC0113
CAMA-1
Human
Tumor Cell Lines
1 vial
Dry Ice
Liquid Nitrogen
Accegen Biotechnology